Search
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 166 - 180 of 794 items.
Janus Kinase Inhibitors and the Risk of Major Adverse Cardiovascular Events, Thrombosis (Including Fatal Events) and Malignancy
AlertHealth professional risk communication | 2022-10-31
POTASSIUM CHLORIDE IN LACTATED RINGER'S INJECTION: Affected lot is labelled with the incorrect strength and ingredient
RecallHealth product recall | 2022-10-24
Children’s ibuprofen/acetaminophen shortage: What you should know and do
AlertPublic advisory | 2022-10-07
Menopur: Potential for a future out of specification result during shelf life
RecallHealth product recall | 2022-09-28
Lumi Lash: Unlicensed product with ingredient on prescription drug list.
RecallHealth product recall | 2022-09-26
Esomeprazole, Candesartan and Pravastatin Tablets: OOS result for Finished Product Assay and/or Blend Uniformity
RecallHealth product recall | 2022-09-21
Venlafaxine: OOS result for Spheroids Dissolution Rate Profile (DRP)
RecallHealth product recall | 2022-09-21
Counterfeit Nuceiva injectable drug seized from New You Spa in Vaughan, Ontario
AlertPublic advisory | 2022-09-06
Quetiapine 25 mg: The affected lot (quetiapine 25 mg) may contain sertraline 50 mg tablets.
RecallHealth product recall | 2022-09-02
Menopur: Out of specification (Assay)
RecallHealth product recall | 2022-08-31
IMBRUVICA (ibrutinib) - Risk of Serious and Fatal Cardiac Arrhythmias or Cardiac Failure
AlertHealth professional risk communication | 2022-08-29
JAMP ATORVASTATIN CALCIUM: Affected lot may be labelled with the incorrect strength on the label.
RecallHealth product recall | 2022-08-29
Recall of one lot of Jamp-Atorvastatin Calcium as some bottles may be labelled as containing 10 mg tablets, but contain 40 mg tablets
AlertPublic advisory | 2022-08-27
Counterfeit Viagra and Cialis erectile dysfunction drugs seized from Grace Daily Mart in Scarborough, Ontario
AlertPublic advisory | 2022-08-25